Repos Pharma Overview
- Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Repos Pharma General Information
Description
Operator of a drug research and development company designed to offer treatment for cancer disease to patients. The company offers re-profiling drugs for treating additional forms of cancer, enabling cancer patients to begin their treatment and get successful cures for cancer.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Bredgrand 14
- 753 20 Uppsala
- Sweden
Repos Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | Completed | Startup |
Repos Pharma Patents
Repos Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210015797-A1 | Treatment for inflammatory disease | Active | 19-Dec-2017 | 00000000000 | |
| US-11504356-B2 | Treatment for inflammatory disease | Active | 19-Dec-2017 | 00000000000 | 0 |
| AU-2018387255-A1 | Treatment for inflammatory disease | Pending | 19-Dec-2017 | 00000000000 | |
| CA-3086101-A1 | Treatment for inflammatory disease | Pending | 19-Dec-2017 | 00000000000 | |
| EP-3727373-A2 | Treatment for inflammatory disease | Pending | 19-Dec-2017 | A61K31/4184 |
Repos Pharma Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Sven Mårten Fryknäs | Co-Founder, Chief Executive Officer, Managing Director & Board Member | ||
| Angelica Loskog | President & Chairman |
Repos Pharma Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Angelica Loskog | Self | President & Chairman | 000 0000 |
| Hans Nygren | Self | Board Member | 000 0000 |
| Rolf Larsson | Self | Board Member | 000 0000 |
Repos Pharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Nxt2b | Venture Capital | Minority | 000 0000 | 000000 0 |